The pair the definition asks for
Germinal center B cells were isolated from the artery tertiary lymphoid organs and lymph nodes of healthy and atherosclerosis-burdened mice, 60 autoantibodies were expression cloned and screened for arterial wall reactivity, and one of them, termed A6, binds histone 2B with high affinity. Vaccination with histone 2B and adoptive transfer of A6 both accelerate atherosclerosis in those mice.[1]
The Witebsky-Rose criteria define an autoimmune disease by exactly this: a pathogenic autoantigen paired with a high-affinity pathogenic autoantibody that causes the disease. By the paper's own account these criteria have not been met for atherosclerosis, and autoimmune disease societies do not list atherosclerosis as an autoimmune disease. What the mouse experiments answer is the definition as it stands inside a mouse model of atherosclerosis.[1]
The 495 who were scanned
Serum anti-H2B antibody titers were determined in a cross-sectional cohort of 495 individuals aged 30 to 70 who underwent chest computed tomography as part of a routine preventive screening program at The First Affiliated Hospital of Sun Yat-sen University, and higher titers were associated with the prevalence of thoracic aortic calcification. Exclusion criteria kept out patients with previously diagnosed cardiovascular diseases, strokes, autoimmune diseases requiring systemic treatment, active malignancies and severe kidney or liver dysfunction.[1]
Those exclusions describe the patients for whom a reclassification would matter most, and a cross-sectional design records who has calcification rather than who later suffers an event. The mouse half of the paper takes its weight from vaccination and transfer experiments, while the human half rests on an association with a structural marker, so the two halves do not measure the same quantity. The opposing reading is fair too: keeping established disease out is the standard way to avoid reverse causation in a screening cohort, and titers may still track events in a study designed to look for them.[1]
The limits the authors set themselves
The authors describe the finding as a potentially important element supporting the autoimmune component of clinically significant atherosclerosis, and they count the limits themselves: the study was performed in a mouse model that does not match all aspects of human atherosclerosis, it was not designed or powered to discover gender differences, and the fully adjusted regression model returned a negative association between systolic blood pressure and thoracic aortic calcification that the cohort was not powered to explain. Andreas Habenicht's statement that the data are likely to have transformative power stands a step ahead of that written conclusion.[1]
The next step follows from those limits: a prospective cohort that measures anti-H2B antibody titers against incident heart attacks and strokes, rather than against calcification seen on a screening scan, makes the clinical meaning of the association testable. Until such a study reports, the honest description of the human evidence is a marker that moves together with disease burden.[1]